Table 1 Patient characteristics
Parameter | Value |
|---|---|
Mean age ± SD, yrs | 72.05 ± 8.86 (57–88) |
Gender, n (male/female) | 7/15 |
Axial length (mm) | 23.55 ± 0.87 (22.51 to 25.71) |
Preoperative phakic / IOL | 19/3 |
ERM stage 1:2:3:4 | 1:3:13:5 |
Internal Limiting Membrane Dye | |
Triamcinolone | 17 |
Indocyanine green | 5 |
Preoperative logMAR BCVA | 0.21 ± 0.25(−0.18 to 0.82) |
Postoperative logMAR BCVA | |
1 month | 0.13 ± 0.21(−0.18 to 0.70) |
3 months | 0.08 ± 0.19(−0.18 to 0.52) |
6 months | 0.02 ± 0.19(− 0.18 to 0.40) |
Preoperative central macular thickness (μm) | 431.0 ± 98.4 (260 to 628) |
Postoperative central macular thickness (μm) | |
1 month | 412.0 ± 52.6 (333 to 498) |
3 months | 390.6 ± 49.3 (308 to 496) |
6 months | 383.1 ± 45.1 (316 to 496) |
Preoperative foveal avascular zone area (mm2) | 0.081 ± 0.068 (0.020 to 0.300) |
Postoperative foveal avascular zone area (mm2) | |
1 month | 0.074 ± 0.035 (0.025 to 0.136) |
3 months | 0.079 ± 0.037 (0.028 to 0.152) |
6 months | 0.079 ± 0.037 (0.029 to 0.161) |